Peptide Registry

MK-677

Price range: $89.00 through $159.00

  • Contents: MK-677 (Ibutamoren; L-163,191; non-peptide oral GHSR-1a agonist)
  • Format: Encapsulated solid
  • Appearance: White to off-white solid
  • Purity: >99%
Quantity Discount Price
1 - 3 - -
4 - 7 10% -
8 + 18% -
SKU: N/A Category: Brand:

Description

MK-677 (Ibutamoren) is a non-peptide small molecule that activates the growth hormone secretagogue receptor (GHSR-1a) through the same Gq/11-coupled calcium signaling cascade as endogenous ghrelin, stimulating pulsatile GH secretion from anterior pituitary somatotrophs and downstream IGF-1 production. Its oral bioavailability and long half-life of approximately 24 hours distinguish it from peptide GHSR-1a agonists such as Ipamorelin and the GHRP series, which require parenteral administration. Capsule format is the mechanistically appropriate delivery method for MK-677 in research models examining sustained GHSR-1a receptor engagement and GH pulse dynamics through oral administration.

Storage and Handling

Store in a cool, dry place away from heat, moisture, and direct light. Keep container tightly sealed when not in use. MK-677 is stable under standard ambient storage conditions; refer to the lot-specific certificate of analysis for recommended conditions.

Compliance Notice

MK-677 capsules are for laboratory research use only. They are not for human or veterinary use and carry no therapeutic, diagnostic, or clinical indication. FDA has not evaluated this product. By purchasing this product, the buyer confirms that they will follow appropriate institutional safety procedures and use it exclusively for controlled research.

Frequently Asked Questions

Why is capsule format the standard format for MK-677 research?

MK-677 is a non-peptide small molecule with well-documented oral bioavailability and a 24-hour half-life following oral administration. Unlike peptide GHSR-1a agonists that require reconstitution and parenteral delivery, MK-677 is designed for oral dosing, making capsule format the mechanistically appropriate delivery method for preclinical research models.

How do the 12.5mg and 25mg capsule options support research design?

The two dose options allow dose-response studies examining GHSR-1a receptor activation and GH pulse dynamics across dose increments without custom weighing, supporting comparative research designs with consistent compound handling.